Lista de obras - Peter Revill - Dominio Público Uruguay

A global scientific strategy to cure hepatitis B

scientific article published on 10 April 2019

A research agenda for curing chronic hepatitis B virus infection.

artículo científico publicado en 2017

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

artículo científico publicado en 2022

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2018

Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease.

artículo científico

Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).

artículo científico publicado en 2016

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

artículo científico publicado en 2015

Characterization of the innate immune signalling pathways in hepatocyte cell lines.

artículo científico publicado en 2008

Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2.

artículo científico publicado en 2009

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients

artículo científico publicado en 2014

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease

artículo científico publicado en 2008

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

artículo científico publicado en 2010

Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

artículo científico publicado en 2015

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user

artículo científico publicado en 2008

Corchorus yellow vein virus, a New World geminivirus from the Old World.

artículo científico publicado en 2006

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2016

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

artículo científico publicado en 2008

Does RNA interference provide new hope for control of chronic hepatitis B infection?

scientific article published on January 2009

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

artículo científico publicado en 2014

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro.

artículo científico publicado en 2016

Ethics and hepatitis B cure research.

artículo científico publicado en 2016

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

artículo científico publicado en 2009

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance.

artículo científico publicado en 2016

Global strategies are required to cure and eliminate HBV infection.

artículo científico publicado en 2016

HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B ⬇️

artículo científico publicado el 1 de enero de 2011

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

artículo científico publicado en 2010

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients.

artículo científico publicado en 2017

Hepatitis B Virus Sensitivity to Interferon-α in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.

artículo científico publicado en 2017

Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance

artículo científico publicado en 2017

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.

artículo científico publicado en 2012

Identification and sequence analysis of potyviruses infecting crops in Vietnam.

artículo científico publicado en 2007

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

artículo científico publicado en 2007

Identification of a subgenomic mRNA encoding the capsid protein of mushroom bacilliform virus, a single-stranded RNA mycovirus.

artículo científico publicado en 1999

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

artículo científico publicado en 2009

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

artículo científico publicado en 2016

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

artículo científico publicado en 2012

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease

artículo científico publicado en 2018

Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood

scientific article published on 27 September 2018

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

artículo científico publicado en 2019

Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia

artículo científico publicado en 2007

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome

article

Mushroom bacilliform virus RNA: the initiation of translation at the 5' end of the genome and identification of the VPg.

artículo científico publicado en 1998

New perspectives on the hepatitis B virus life cycle in the human liver.

artículo científico

On the evolution and molecular epidemiology of the potyvirus Papaya ringspot virus

artículo científico publicado en 2002

Overview of hepatitis B viral replication and genetic variability

artículo científico publicado en 2016

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

artículo científico publicado en 2013

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.

artículo científico publicado en 2016

Sequence diversity of South Pacific isolates of Taro bacilliform virus and the development of a PCR-based diagnostic test.

artículo científico publicado en 2003

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

artículo científico publicado en 2016

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

artículo científico publicado en 2009

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody ⬇️

artículo científico publicado el 15 de enero de 2011

Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirus.

artículo científico publicado en 2005

Taxonomy of the order Mononegavirales: update 2017.

artículo científico publicado en 2017

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.

artículo científico publicado en 2015

Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

artículo científico publicado en 2011

Viral factors and predicting disease outcomes in chronic hepatitis B.

artículo científico publicado en 2014

Lista de obras de Peter Revill

A global scientific strategy to cure hepatitis B

A research agenda for curing chronic hepatitis B virus infection.

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease.

Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Characterization of the innate immune signalling pathways in hepatocyte cell lines.

Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2.

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user

Corchorus yellow vein virus, a New World geminivirus from the Old World.

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

Does RNA interference provide new hope for control of chronic hepatitis B infection?

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro.

Ethics and hepatitis B cure research.

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance.

Global strategies are required to cure and eliminate HBV infection.

HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B ⬇️

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients.

Hepatitis B Virus Sensitivity to Interferon-α in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.

Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.

Identification and sequence analysis of potyviruses infecting crops in Vietnam.

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

Identification of a subgenomic mRNA encoding the capsid protein of mushroom bacilliform virus, a single-stranded RNA mycovirus.

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease

Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome

Mushroom bacilliform virus RNA: the initiation of translation at the 5' end of the genome and identification of the VPg.

New perspectives on the hepatitis B virus life cycle in the human liver.

On the evolution and molecular epidemiology of the potyvirus Papaya ringspot virus

Overview of hepatitis B viral replication and genetic variability

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.

Sequence diversity of South Pacific isolates of Taro bacilliform virus and the development of a PCR-based diagnostic test.

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody ⬇️

Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirus.

Taxonomy of the order Mononegavirales: update 2017.

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.

Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Viral factors and predicting disease outcomes in chronic hepatitis B.